EUVIMEDEUVIMED entdecken
Crossref

Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy

Gabriel Castillo, William Beaty, Olivia Delau, Keith Sultan, Dana Lukin, Adam S Faye, Sonia Friedman, Jordan Axelrad

Digestive Diseases and Sciences · 2026

DOI: 10.1007/s10620-025-09652-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2026. Verfasst von Gabriel Castillo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, NYU Grossman School of Medicine Health, New York, NY, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Sexual Dysfunction, Physiological, Crohn Disease, Biological Products. Die Arbeit nennt 19 Literaturangaben. Gefördert von: NIDDK NIH HHS, New York Crohn's and Colitis Organization, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with inflammatory bowel disease (IBD) experience increased rates of sexual dysfunction (SD). This study investigated SD longitudinally in patients initiating a biologic or small molecule therapy. METHODS: Patients with Crohn's disease (CD) or ulcerative colitis (UC) starting biologic or small molecule therapy were surveyed at induction, 2 months, and 6 months. Measures included the IBD-Female and Male Sexual Dysfunction Scales (FSDS, MSDS), PROMIS Sexual Function and Satisfaction Brief Profile, Harvey Bradshaw Index (HBI), Simple Clinical Colitis Activity Index (SCCAI), partial Mayo score, Short IBD Questionnaire (SIBDQ), PHQ-9, and IBD Disability Index (IBDDI). Endoscopic and biomarker data were collected. Correlations, longitudinal changes, and predictors of SD were analyzed. RESULTS: A total of 170 patients (89 males, 81 females) completed baseline surveys, 132 at 2 months, and 115 at 6 months. Median age was 31.5 years; 59% had CD. At baseline, median HBI was 5.5, SCCAI 6, and pMayo 4. SD scores correlated with clinical disease activity (p < 0.05) but not consistently with endoscopic or biomarker measures. SD was associated with impaired quality of life, depression, and disability (p < 0.05). Among responders to therapy, SD, SIBDQ, and IBDDI significantly improved (p < 0.05). Multivariate analysis showed that more severe clinical disease activity predicted worse SD, while time after therapy initiation and improved quality of life were independently associated with better SD. CONCLUSIONS: Advanced therapy can improve SD in IBD. Improvements appear to be mediated by reductions in clinical disease activity and psychosocial factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeSexual Dysfunction, PhysiologicalCrohn DiseaseBiological ProductsHumansFemaleAdultMaleLongitudinal StudiesMiddle AgedYoung AdultQuality of LifeSeverity of Illness IndexSurveys and Questionnaires

Stichwörter der Autor:innen

Inflammatory bowel diseasePsychosocialQuality of lifeSexual dysfunction

Substanzen

Biological Products

Autor:innen und Institutionen

  • Division of Gastroenterology, NYU Grossman School of Medicine Health, New York, NY, USA.
  • Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell Health, New York, NY, USA.
  • Division of Gastroenterology and Hepatology, Weil Cornell Medical Center, New York, NY, USA.
  • Division of Gastroenterology, Hepatology, and Endoscopy, Tufts University School of Medicine, Boston, MA, USA.
  • Division of Gastroenterology, NYU Grossman School of Medicine Health, New York, NY, USA. Jordan.Axelrad@nyulangone.org.

Förderung

  • NIDDK NIH HHS
  • New York Crohn's and Colitis Organization
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Castillo, G., Beaty, W., Delau, O., Sultan, K., Lukin, D., Faye, A. S., Friedman, S., & Axelrad, J. (2026). Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09652-1

Vancouver

Castillo G, Beaty W, Delau O, Sultan K, Lukin D, Faye AS, et al. Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy. Digestive Diseases and Sciences. 2026. doi:10.1007/s10620-025-09652-1

BibTeX
@article{Castillo2026,
  author = {Castillo, Gabriel and Beaty, William and Delau, Olivia and Sultan, Keith and Lukin, Dana and Faye, Adam S and Friedman, Sonia and Axelrad, Jordan},
  title = {Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy},
  journal = {Digestive Diseases and Sciences},
  year = {2026},
  doi = {10.1007/s10620-025-09652-1}
}
Kostenlos starten →